Class III · Low risk
Doxazosin Tablets
Tablets/Capsules Imprinted with Wrong ID
Is Doxazosin recalled?
Yes — there is an active recall. 4 ongoing FDA recalls mention Doxazosin (16 total). Check the affected lots below.
Most common reason: cGMP deviation (8 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Doxazosin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Doxazosin recalls in 2026
1 initiated in 2026, 16 in total — newest first
Class II · Moderate risk
Cardura XL
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Class II · Moderate risk
Cardura XL
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Class II · Moderate risk
Cardura XL
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Cardura XL
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Doxazosin Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Doxazosin Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Doxazosin 2 mg tablets
cGMP Deviations
Class II · Moderate risk
Doxazosin Tablets
CGMP Deviations
Class II · Moderate risk
Doxazosin Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Doxazosin Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Doxazosin Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Doxazosin Tablets USP 1 mg
CGMP Deviations: recalling drug products following an FDA inspection.
Class III · Low risk
Cardura XL
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Class II · Moderate risk
Doxazosin Mesylate
Labeling: Label Mixup: DOXAZOSIN MESYLATE, Tablet, 1 mg may have potentially been mislabeled as the following drug: PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: W003872, EXP: 6/27/2014.
Class II · Moderate risk
Doxazosin Tablets
Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.